Laverdia-CA1 (Verdinexor) Tablets for Dogs are formulated as a conditionally FDA approved antineoplastic, working to treat lymphoma in canines. Featuring the active ingredient verdinexor, these Laverdia-CA1 dog tablets work by preventing proteins from leaving the cell nucleus, which helps to kill and eliminate cancer cells. Available in 50 ct. bottles in 2.5 mg, 10 mg and 50 mg of Laverdia-CA1.How it Works

Laverdia-CA1 contains verdinexor, which disrupts - and eventually kills - cancer cells by stopping tumor suppressing proteins.

Special Precautions

Laverdia-CA is for use only in dogs. It is conditionally approved to treat lyphoma in canines, and it is not for use in humans. Nursing woman, pregnant woman, or those who may become pregnant should handle or administer Laverdia-CA1. Additionally, they should not come in contact with urine, feces, saliva, or vomit of dogs who have been treated with the drug within the past 3 days. Laverdia-CA1 may affect the male fertility. It's advised to wear chemotherapy resistant gloves when handling Laverdia-CA1. Do not use in pregnant or lactating dogs or dogs used for breeding.

Overdose Information

Contact your nearest emergency animal hospital.

Side Effects

Anorexia, weigh loss, elevated liver enzymes, vomiting, and diarrhea are among the most common side effects of dogs taking Laverdia-CA1.

Storage

Store the bottles at controlled room temperature 20° to 25°C (68° - 77°F).